{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:30:06Z","timestamp":1792416606717,"version":"4.4.0"},"reference-count":211,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.591894","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T06:08:25Z","timestamp":1604383705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation"],"prefix":"10.3389","volume":"11","author":[{"given":"Rittika","family":"Chunder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Schropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kuerten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/ar2780","article-title":"B cells in autoimmunity","volume":"11","author":"D\u00f6rner","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"215308","DOI":"10.6064\/2012\/215308","article-title":"B cells in autoimmune diseases","volume":"2012","author":"Hampe","year":"2012","journal-title":"Scientifica."},{"key":"B3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/187152612800564437","article-title":"Unraveling effector functions of B cells during infection: the hidden world beyond antibody production","volume":"12","author":"Le\u00f3n","year":"2012","journal-title":"Infect Disord Drug Targets"},{"key":"B5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.coi.2008.03.003","article-title":"Cytokine-producing B lymphocytes\u2014key regulators of immunity","volume":"20","author":"Lund","year":"2008","journal-title":"Curr Opin Immunol."},{"key":"B6","first-page":"82","article-title":"Specific B lymphocytes efficiently pick up, process and present antigen to T cells","volume":"77","author":"Lanzavecchia","year":"1985","journal-title":"Behring Inst Mitt."},{"key":"B7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","article-title":"Targeting B cells and plasma cells in autoimmune diseases","volume":"9","author":"Hofmann","year":"2018","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3389\/fimmu.2018.01941","article-title":"T cell\/B cell collaboration and autoimmunity: an intimate relationship","volume":"9","author":"Petersone","year":"2018","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13044-018-0046-9","article-title":"Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases","volume":"11","author":"Rydzewska","year":"2018","journal-title":"Thyroid Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/08916934.2017.1280028","article-title":"B cell contribution of the CD4+ T cell inflammatory phenotypes in systemic lupus erythematosus","volume":"50","author":"Choi","year":"2017","journal-title":"Autoimmunity."},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clim.2017.07.020","article-title":"B cells and their cytokine activities implications in human diseases","volume":"186","author":"Fillatreau","year":"2018","journal-title":"Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fimmu.2018.00622","article-title":"B cell modulation strategies in autoimmune diseases: new concepts","volume":"9","author":"Musette","year":"2018","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.32607\/20758251-2018-10-3-11-22","article-title":"B cell regulation in autoimmune diseases","volume":"10","author":"Sokolov","year":"2018","journal-title":"Acta Naturae."},{"key":"B17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/cmi.2012.60","article-title":"Regulatory B cells in autoimmune diseases","volume":"10","author":"Yang","year":"2013","journal-title":"Cell Mol Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1749-6632.2009.04651.x","article-title":"Regulatory B cells in autoimmune diseases: how do they work?","volume":"1173","author":"Lemoine","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139","author":"DiSabato","year":"2016","journal-title":"J Neurochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cnr.2006.09.004","article-title":"The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival","volume":"6","author":"Carson","year":"2006","journal-title":"Clin Neurosci Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/13550280290168631","article-title":"Neural immunity: friend or foe?","volume":"8","author":"Gendelman","year":"2002","journal-title":"J Neurovirol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.it.2016.08.001","article-title":"Neurological disease as a failure of brain\u2013immune crosstalk: the multiple faces of neuroinflammation","volume":"37","author":"Schwartz","year":"2016","journal-title":"Trends Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s13311-015-0385-3","article-title":"Neuroinflammation: ways in which the immune system affects the brain","volume":"12","year":"2015","journal-title":"Neurotherapeutics."},{"key":"B24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1530\/VB-19-0033","article-title":"Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation","volume":"2","author":"Marchetti","year":"2020","journal-title":"Vascular Biology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2559","DOI":"10.1371\/journal.pone.0002559","article-title":"B cells accumulate in the cerebrospinal fluid in inflammatory neurological diseases","volume":"1","author":"Gredler","year":"2012","journal-title":"J Cytol Histol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00415-013-7145-2","article-title":"Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases","volume":"261","author":"Kowarik","year":"2014","journal-title":"J Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat Rev Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3389\/fimmu.2015.00565","article-title":"The ins and outs of B cells in multiple sclerosis","volume":"6","author":"Blauth","year":"2015","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","year":"2018","journal-title":"Nat Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/ijms18102048","article-title":"Deciphering the Role of B cells in multiple sclerosis\u2014towards specific targeting of pathogenic function","volume":"18","author":"Lehmann-Horn","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development","volume":"131","author":"Pieper","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1172\/JCI78083","article-title":"Checkpoints that control B cell development","volume":"125","year":"2015","journal-title":"J Clin Invest."},{"key":"B36","volume-title":"Roitt's Essential Immunology. 12th edn","author":"Delves","year":"2011"},{"key":"B37","volume-title":"Kuby Immunology. 6th edn","author":"Punt","year":"2012"},{"key":"B38","unstructured":"Plasma cells\n            WolsHAM\n          eLS.2006"},{"key":"B39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nri2133","article-title":"B-cell anergy: from transgenic models to naturally occurring anergic B cells?","volume":"7","author":"Cambier","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jtbi.2014.08.034","article-title":"Molecular mimicry and clonal deletion: a fresh look","volume":"375","author":"Rose","year":"2015","journal-title":"J Theor Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/s1074-7613(00)80029-1","article-title":"Negative selection of immature B Cells by receptor editing or deletion is determined by site of antigen encounter","volume":"10","author":"Sandel","year":"1999","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1073\/pnas.73.10.3628","article-title":"Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions","volume":"73","author":"Hozumi","year":"1976","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/cmi.2012.63","article-title":"Regulatory functions of innate-like B cells","volume":"10","author":"Zhang","year":"2013","journal-title":"Cell Mol Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nri953","article-title":"Lymphoid malignancies: the dark side of B-cell differentiation","volume":"2","author":"Shaffer","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","article-title":"Peripheral B cell subsets","volume":"20","author":"Allman","year":"2008","journal-title":"Curr Opin Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cmi.2012.61","article-title":"TLR signaling in B-cell development and activation","volume":"10","author":"Hua","year":"2013","journal-title":"Cell Mol Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fimmu.2014.00092","article-title":"Early BCR events and antigen capture, processing, and loading on MHC class II on B cells","volume":"5","author":"Avalos","year":"2014","journal-title":"Front Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0167-5699(88)91223-6","article-title":"The lymph follicle: a hard nut to crack","volume":"9","author":"Heinen","year":"1988","journal-title":"Immunol Today."},{"key":"B49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.20052036","article-title":"T-independent type II immune responses generate memory B cells","volume":"203","author":"Obukhanych","year":"2006","journal-title":"J Exp Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"932351","DOI":"10.4061\/2011\/932351","article-title":"Heterogeneity in multiple sclerosis: scratching the surface of a complex disease","volume":"2011","author":"Disanto","year":"2010","journal-title":"Autoimmune Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain."},{"key":"B54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/1352458513476563","article-title":"Relapsing-remitting and primary progressive MS have the same cause(s)\u2014the neuropathologist's view: 2","volume":"19","author":"Kuhlmann","year":"2013","journal-title":"Mult Scler."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1759-1961.2009.00003.x","article-title":"What drives disease in multiple sclerosis: inflammation or neurodegeneration?","volume":"1","author":"Lassmann","year":"2010","journal-title":"Clin Exp Neuroimmunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbadis.2010.07.020","article-title":"MS and the B cell controversy","volume":"1812","author":"Cross","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/01.wco.0000169737.99040.31","article-title":"Pathogenesis of multiple sclerosis","volume":"18","author":"Prat","year":"2005","journal-title":"Curr Opin Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3389\/fimmu.2015.00642","article-title":"B cells are multifunctional players in multiple sclerosis pathogenesis: insights from therapeutic interventions","volume":"6","author":"Claes","year":"2015","journal-title":"Front Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2011.03.024","article-title":"Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone","volume":"34","author":"Kerfoot","year":"2011","journal-title":"Immunity."},{"key":"B61","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1474-4422(08)70192-3","article-title":"B cells and multiple sclerosis","volume":"7","author":"Franciotta","year":"2008","journal-title":"Lancet Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/WCO.000000000000563","article-title":"B cells in multiple sclerosis","volume":"31","author":"Sospedra","year":"2018","journal-title":"Curr Opin Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2019.00201","article-title":"The role of B Cells and antibodies in multiple sclerosis, neuromyelitis optica, and related disorders","volume":"10","author":"H\u00e4usser-Kinzel","year":"2019","journal-title":"Front Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12974-019-1517-1","article-title":"Impact of B cells to the pathophysiology of multiple sclerosis","volume":"16","author":"Arneth","year":"2019","journal-title":"J Neuroinflammation."},{"key":"B65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","article-title":"The cerebrospinal fluid in multiple sclerosis","volume":"10","author":"Deisenhammer","year":"2019","journal-title":"Front Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-444-52001-2.00003-0","article-title":"The good and the bad of neuroinflammation in multiple sclerosis","volume":"122","author":"Naegele","year":"2014","journal-title":"Handb Clin Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm1714","article-title":"Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis","volume":"14","author":"Obermeier","year":"2008","journal-title":"Nat Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain."},{"key":"B70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2006.06.031","article-title":"Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation","volume":"180","author":"Cepok","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.4049\/jimmunol.164.5.2782","article-title":"Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients","volume":"164","author":"Colombo","year":"2000","journal-title":"J Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jneuroim.2006.10.020","article-title":"Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection","volume":"183","author":"Harp","year":"2007","journal-title":"J Neuroimmunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/scitranslmed.3008879","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6","author":"Stern","year":"2014","journal-title":"Sci Transl Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/scitranslmed.3008930","article-title":"Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis","volume":"6","author":"Palanichamy","year":"2014","journal-title":"Sci Transl Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e92724","DOI":"10.1172\/jci.insight.92724","article-title":"Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients","volume":"2","author":"Eggers","year":"2017","journal-title":"JCI Insight."},{"key":"B76","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::aid-ana3>3.0.co;2-q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s1471-4914(00)01909-2","article-title":"Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy","volume":"7","author":"Lassmann","year":"2001","journal-title":"Trends Mol Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells","volume":"141","author":"Machado-Santos","year":"2018","journal-title":"Brain."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain."},{"key":"B82","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain."},{"key":"B85","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fimmu.2016.00451","article-title":"Tertiary lymphoid organs in central nervous system autoimmunity","volume":"7","author":"Mitsdoerffer","year":"2016","journal-title":"Front Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/brain\/awq350","article-title":"Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis","volume":"134","author":"Lovato","year":"2011","journal-title":"Brain."},{"key":"B87","doi-asserted-by":"publisher","first-page":"779","DOI":"10.org\/10.1111\/bpa.12841","article-title":"B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis","volume":"30","author":"Reali","year":"2020","journal-title":"Brain Pathol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/13550289609146888","article-title":"Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction","volume":"2","author":"Sanders","year":"1996","journal-title":"J Neurovirol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00415-005-0794-z","article-title":"Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response","volume":"252","author":"Derfuss","year":"2005","journal-title":"J Neurol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20041674","article-title":"BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma","volume":"201","author":"Krumbholz","year":"2005","journal-title":"J Exp Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/brain\/awh680","article-title":"Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment","volume":"129","author":"Krumbholz","year":"2006","journal-title":"Brain."},{"key":"B93","unstructured":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation111\n            KowarikMC\n            CepokS\n            SellnerJ\n            GrummelV\n            WeberMS\n            KornT\n          22591862J Neuroinflammation.92012"},{"key":"B94","doi-asserted-by":"publisher","first-page":"706383","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"13","author":"Hauser","year":"2008","journal-title":"N Engl J Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1212\/WNL.0000000000003331","article-title":"Rituximab in multiple sclerosis: a retrospective observational study on safety and efficacy","volume":"87","author":"Salzer","year":"2016","journal-title":"Neurology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.06.029","article-title":"Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients","volume":"180","author":"Cross","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archneurol.2009.157","article-title":"Depletion of B lymphocytes from cerebral perivascular spaces by rituximab","volume":"66","author":"Martin Mdel","year":"2009","journal-title":"Arch Neurol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.msard.2016.01.001","article-title":"The effects of intrathecal rituximab on biomarkers in multiple sclerosis","volume":"6","author":"Topping","year":"2016","journal-title":"Mult Scler Relat Disord."},{"key":"B99","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/acn3.293","article-title":"Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis","volume":"3","author":"Komori","year":"2016","journal-title":"Ann Clin Transl Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/eji.201646485","article-title":"Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis","volume":"46","author":"Martin","year":"2016","journal-title":"Eur J Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","year":"2017","journal-title":"N Engl J Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cellimm.2006.02.005","article-title":"B cells as antigen presenting cells","volume":"238","author":"Rodr\u00edguez-Pinto","year":"2005","journal-title":"Cell Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.4049\/jimmunol.1301284","article-title":"B cell antigen presentation in the initiation of follicular helper T cell and germinal center differentiation","volume":"192","author":"Barnett","year":"2014","journal-title":"J Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1172\/JCI119455","article-title":"Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy","volume":"99","author":"Gen\u00e7","year":"1997","journal-title":"J Clin Invest."},{"key":"B105","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2249.2004.02624.x","article-title":"Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis","volume":"138","author":"Marckmann","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1352458516664210","article-title":"Increased ex vivo antigen presentation profile of B cells in multiple sclerosis","volume":"23","author":"Mathias","year":"2017","journal-title":"Mult Scler"},{"key":"B107","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1515\/revneuro-2014-0026","article-title":"Role of toll-like receptors in multiple sclerosis","volume":"2","author":"Miranda-Hernandez","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fnmol.2019.00314","article-title":"Inflammatory role of TLR-MyD88 signaling in multiple sclerosis","volume":"12","author":"Zheng","year":"2020","journal-title":"Front Mol Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1365-3083.2002.01093.x","article-title":"CD80 expression is induced on activated B cells following stimulation by CD86","volume":"55","author":"Sahoo","year":"2002","journal-title":"Scand J Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1002\/eji.201040516","article-title":"Memory B cells from a subset of treatment-na\u00efve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-\u03b3 production in response to myelin basic protein and myelin oligodendrocyte glycoprotein","volume":"40","author":"Harp","year":"2010","journal-title":"Eur J Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4049\/jimmunol.1601649","article-title":"Dimethyl fumarate treatment mediates an anti-inflammatory shift in B cell subsets of patients with multiple sclerosis","volume":"198","author":"Li","year":"2017","journal-title":"J Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","article-title":"Distinct profiles of human B cell effector cytokines: a role in immune regulation?","volume":"172","year":"2004","journal-title":"J Immunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","year":"2010","journal-title":"Ann Neurol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro","volume":"246","author":"Lisak","year":"2012","journal-title":"J Neuroimmunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jneuroim.2017.05.004","article-title":"B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro","volume":"309","author":"Lisak","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4049\/jimmunol.1600089","article-title":"Features of human CD3+CD20+ T cells","volume":"197","author":"Schuh","year":"2016","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"25800","DOI":"10.1073\/pnas.1915309116","article-title":"JJ, Wilson MR, Calabresi PA, Hauser SL, Schneck JP, Zamvil SS. Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis","volume":"116","author":"Sabatino","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B122","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awy301","article-title":"Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis","volume":"142","author":"von Essen","year":"2019","journal-title":"Brain"},{"key":"B123","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4103\/1673-5374.266913","article-title":"Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab","volume":"15","author":"Gingele","year":"2020","journal-title":"Neural Regen Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"580","DOI":"10.4049\/jimmunol.1400118","article-title":"Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients","volume":"193","author":"Palanichamy","year":"2014","journal-title":"J Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells8010012","article-title":"Ocrelizumab depletes CD20? T cells in multiple sclerosis patients","volume":"8","author":"Gingele","year":"2018","journal-title":"Cells"},{"key":"B126","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br J Pharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20090299","article-title":"Spontaneous relapsing-remitting EAE in the SJL\/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells","volume":"206","author":"P\u00f6llinger","year":"2009","journal-title":"J Exp Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"B130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-444-63432-0.00008-6","article-title":"Neurologic autoimmunity","volume":"133","author":"Bradl","year":"2016","journal-title":"Handb Clin Neurol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.it.2013.04.006","article-title":"Modeling the heterogeneity of multiple sclerosis in animals","volume":"34","author":"Simmons","year":"2013","journal-title":"Trends Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","article-title":"Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation","volume":"35","author":"Peters","year":"2011","journal-title":"Immunity."},{"key":"B133","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jneuroim.2006.03.021","article-title":"MBP-PLP fusion protein-induced EAE in C57BL\/6 mice","volume":"177","author":"Kuerten","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2012.12.007","article-title":"The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response","volume":"146","author":"Hundgeburth","year":"2013","journal-title":"Clin Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2011.03.009","article-title":"Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE","volume":"140","author":"Kuerten","year":"2011","journal-title":"Clin Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.clim.2008.07.016","article-title":"Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35\u201355-induced experimental autoimmune encephalomyelitis","volume":"129","author":"Kuerten","year":"2008","journal-title":"Clin Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-012-1023-3","article-title":"Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response","volume":"124","author":"Kuerten","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2015.03.009","article-title":"Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis","volume":"158","author":"Batoulis","year":"2015","journal-title":"Clin Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-065x.1988.tb00778.x","article-title":"Antigen-presenting function of B lymphocytes","volume":"106","author":"Pierce","year":"1988","journal-title":"Immunol Rev."},{"key":"B140","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity: B cells in CNS autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e0199694","DOI":"10.1371\/journal.pone.0199694","article-title":"B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis","volume":"13","author":"Harp","year":"2018","journal-title":"PLoS ONE."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II\u2013dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature."},{"key":"B144","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1172\/JCI36030","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest."},{"key":"B145","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1073\/pnas.1810470115","article-title":"Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease","volume":"115","author":"H\u00e4usler","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B146","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases","volume":"13","author":"Chen","year":"2016","journal-title":"Mol Med Rep."},{"key":"B147","doi-asserted-by":"publisher","first-page":"952375","DOI":"10.1155\/2013\/952375","article-title":"Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease","volume":"2013","year":"2013","journal-title":"Mediators Inflamm."},{"key":"B148","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.immuni.2007.09.002","article-title":"Antibodies and B cell memory in viral Immunity","volume":"27","author":"D\u00f6rner","year":"2007","journal-title":"Immunity."},{"key":"B150","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1126\/science.271.5246.173","article-title":"Immunology taught by viruses","volume":"271","author":"Zinkernagel","year":"1996","journal-title":"Science."},{"key":"B151","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell."},{"key":"B152","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","article-title":"Viral diseases of the central nervous system","volume":"11","author":"Swanson II","year":"2015","journal-title":"Curr Opin Virol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijid.2018.06.008","article-title":"Epidemiology and clinical outcomes of viral central nervous system infections","volume":"73","author":"Abid","year":"2018","journal-title":"Int J Infect Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/jnnp.2003.034280","article-title":"Viral encephalitis causes, differential diagnosis and management","volume":"75","author":"Kennedy","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B155","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s13365-014-0294-y","article-title":"Immunology of progressive multifocal leukoencephalopathy","volume":"21","author":"Jelcic","year":"2015","journal-title":"J Neurovirol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with Natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N Engl J Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fimmu.2015.00241","article-title":"B cells and progressive multifocal leukoencephalopathy: search for the missing link","volume":"6","author":"Durali","year":"2015","journal-title":"Front Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e2077","DOI":"10.1002\/rmv.2077","article-title":"Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: what do we know after 20 years of rituximab","volume":"29","author":"Focosi","year":"2019","journal-title":"Rev Med Virol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4049\/jimmunol.168.3.1204","article-title":"Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells","volume":"168","author":"Ramakrishna","year":"2002","journal-title":"J Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/infdis\/jix513","article-title":"Humoral immune responses against zika virus infection and the importance of preexisting flavivirus immunity","volume":"216","author":"Priyamvada","year":"2017","journal-title":"J Infect Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/cimm.2000.1613","article-title":"B cells and antibodies in the pathogenesis of myelin injury in semliki forest virus encephalomyelitis","volume":"200","author":"Smith-Norowitz","year":"2000","journal-title":"Cell Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.4049\/jimmunol.1400654","article-title":"Infiltrating regulatory B cells control neuroinflammation following viral brain infection","volume":"193","author":"Mutnal","year":"2014","journal-title":"J Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1371\/journal.pntd.0000535","article-title":"The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system","volume":"3","author":"Hooper","year":"2009","journal-title":"PLoS Negl Trop Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"Cells and antibody play critical roles in the immediate defense of disseminated infection by west nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/eji.200535123","article-title":"CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS","volume":"36","author":"Tschen","year":"2006","journal-title":"Eur J Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1128\/jvi.00202-11","article-title":"CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis","volume":"85","author":"Marques","year":"2011","journal-title":"J Virol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/JVI.01769-12","article-title":"Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis","volume":"87","author":"Metcalf","year":"2013","journal-title":"J Virol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-016-0582-y","article-title":"Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection","volume":"13","author":"Lokensgard","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B169","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-immunol-042718-041417","article-title":"Neuroinflammation during RNA viral infections","volume":"37","author":"Klein","year":"2019","journal-title":"Annu Rev Immunol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbi.2016.01.016","article-title":"CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis","volume":"54","author":"Phares","year":"2016","journal-title":"Brain Behav Immun."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1128\/JVI.02260-10","article-title":"Factors supporting intrathecal humoral responses following viral encephalomyelitis","volume":"85","author":"Phares","year":"2011","journal-title":"J Virol"},{"key":"B172","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/B978-0-444-63269-2.00023-4","article-title":"Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) and autoimmunity","volume-title":"Infection Autoimmunity","author":"Chastain","year":"2015"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3389\/fimmu.2019.01821","article-title":"Central nervous system inflammatory aggregates in the Theiler's virus model of progressive multiple sclerosis","volume":"10","author":"DiSano","year":"2019","journal-title":"Front Immunol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbi.2016.09.022","article-title":"Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis","volume":"60","author":"DiSano","year":"2017","journal-title":"Brain Behav Immun."},{"key":"B175","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2174\/187152712801661220","article-title":"Viruses and multiple sclerosis","volume":"11","author":"Virtanen","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e0192109","DOI":"10.1371\/journal.pone.0192109","article-title":"Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells","volume":"13","author":"Hassani","year":"2018","journal-title":"PLoS ONE"},{"key":"B177","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26188","article-title":"Epstein Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice","author":"Polepole","year":"2020","journal-title":"J Med Virol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4049\/jimmunol.1700178","article-title":"EBV Infection empowers human B cells for autoimmunity: role of autophagy and relevance to multiple sclerosis","volume":"199","author":"Morandi","year":"2017","journal-title":"J Immunol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12974-017-1049-5","article-title":"Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis","volume":"15","author":"Veroni","year":"2018","journal-title":"J Neuroinflammation."},{"key":"B182","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis","volume":"17","author":"Pender","year":"2011","journal-title":"Neuroscientist."},{"key":"B183","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-barr virus in multiple sclerosis: theory and emerging immunotherapies","volume":"26","year":"2020","journal-title":"Trends Mol Med."},{"key":"B184","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41435-019-0089-5","article-title":"Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein\u2013Barr Virus hypomethylated regions","volume":"21","author":"Ong","year":"2020","journal-title":"Genes Immun."},{"key":"B185","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1212\/NXI.0000000000000466","article-title":"Molecular signature of Epstein-Barr virus infection in MS brain lesions","volume":"5","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B186","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","article-title":"Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation","volume":"69","author":"Serafini","year":"2010","journal-title":"J Neuropathol Exp Neurol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3389\/fimmu.2018.03092","article-title":"Do antiretroviral drugs protect from multiple sclerosis by inhibiting expression of MS-associated retrovirus?","volume":"9","author":"Morandi","year":"2019","journal-title":"Front Immunol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"e44991","DOI":"10.1371\/journal.pone.0044991","article-title":"Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis","volume":"7","author":"Mameli","year":"2012","journal-title":"PLoS ONE"},{"key":"B189","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1093\/brain\/awp296","article-title":"Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"133","author":"Peferoen","year":"2010","journal-title":"Brain."},{"key":"B190","doi-asserted-by":"publisher","first-page":"22932","DOI":"10.1073\/pnas.2008523117","article-title":"A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis","volume":"117","author":"Ramesh","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B191","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fimmu.2014.00552","article-title":"Immunity to cytomegalovirus in early life","volume":"5","author":"Huygens","year":"2014","journal-title":"Front Immunol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1212\/WNL.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology."},{"key":"B194","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41598-017-00645-3","article-title":"Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation","volume":"7","author":"Vanheusden","year":"2017","journal-title":"Sci Rep."},{"key":"B195","doi-asserted-by":"publisher","first-page":"472978","DOI":"10.1155\/2014\/472978","article-title":"Human cytomegalovirus and autoimmune disease","volume":"2014","author":"Halenius","year":"2014","journal-title":"Biomed Res Int."},{"key":"B196","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1352458513494489","article-title":"Cytomegalovirus seropositivity is negatively associated with multiple sclerosis","volume":"20","author":"Sundqvist","year":"2014","journal-title":"Mult Scler."},{"key":"B197","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jinf.2019.10.017","article-title":"The different responses to cytomegalovirus (CMV) Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls","volume":"80","author":"Maple","year":"2020","journal-title":"J Infect."},{"key":"B198","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12974-020-01840-2","article-title":"Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis","volume":"17","author":"Zabalza","year":"2020","journal-title":"J Neuroinflammation."},{"key":"B199","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","article-title":"IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection","volume":"189","author":"Das","year":"2012","journal-title":"J Immunol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbadis.2010.06.012","article-title":"Viral triggers of multiple sclerosis","volume":"1812","author":"Kakalacheva","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B201","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.1073\/pnas.0402455101","article-title":"Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis","volume":"101","author":"Corcione","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B202","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann Neurol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.msard.2016.07.011","article-title":"CD20 Therapies in multiple sclerosis and experimental autoimmune encephalomyelitis\u2014targeting T or B cells?","volume":"9","author":"Agahozo","year":"2016","journal-title":"Mult Scler Relat Disord."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/NEN.0b013e3181b4bf8f","article-title":"Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis","volume":"68","author":"Kooi","year":"2009","journal-title":"J Neuropathol Exp Neurol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/nyas.12137","article-title":"Human B-1 cells take the stage","volume":"1285","author":"Rothstein","year":"2013","journal-title":"Ann N Y Acad Sci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxv038","article-title":"The expanding family of regulatory B cells","volume":"27","author":"Mauri","year":"2015","journal-title":"Int Immunol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-017-0152-y","article-title":"Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation","volume":"9","author":"Peng","year":"2018","journal-title":"Cell Death Dis."},{"key":"B208","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity."},{"key":"B209","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1756285616666741","article-title":"Targeting B cells in relapsing\u2013remitting multiple sclerosis: from pathophysiology to optimal clinical management","volume":"10","author":"Bittner","year":"2017","journal-title":"Ther Adv Neurol Disord."},{"key":"B210","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8+ T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/brain\/awh578","article-title":"Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?","volume":"128","author":"Friese","year":"2005","journal-title":"Brain."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.591894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T06:08:40Z","timestamp":1604383720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.591894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":211,"alternative-id":["10.3389\/fneur.2020.591894"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.591894","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"article-number":"591894"}}